Treatment of hypertension in the elderly.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects; D002561:Cerebrovascular Disorders / Q000401:mortality / Q000517:prevention & control; D003000:Clonidine / Q000627:therapeutic use; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use; D005128:Eye Diseases / Q000517:prevention & control; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006331:Heart Diseases / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D007022:Hypotension / Q000209:etiology; D008750:Methyldopa / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000517:prevention & control; D010276:Parasympatholytics / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal; D011926:Rauwolfia / Q000627:therapeutic use; D014652:Vascular Diseases / Q000517:prevention & control
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D005730:Ganglionic Blockers; D010276:Parasympatholytics; D008750:Methyldopa; D003000:Clonidine